CRISPR Therapeutics AG banner

CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 56.045 USD -2.24% Market Closed
Market Cap: $5.3B

Intrinsic Value

The intrinsic value of one CRSP stock under the Base Case scenario is 6.686 USD. Compared to the current market price of 56.045 USD, CRISPR Therapeutics AG is Overvalued by 88%.

CRSP Intrinsic Value
6.686 USD
Overvaluation 88%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CRISPR Therapeutics AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about CRSP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CRSP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CRISPR Therapeutics AG.

Explain Valuation
Alternatives to CRSP

Wall St
Price Targets

Dividends

CRISPR Therapeutics AG
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

CRSP Insider Trading
Buy and sell transactions by insiders

CRSP News

What is the Intrinsic Value of one CRSP stock?

The intrinsic value of one CRSP stock under the Base Case scenario is 6.686 USD.

Is CRSP stock undervalued or overvalued?

Compared to the current market price of 56.045 USD, CRISPR Therapeutics AG is Overvalued by 88%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett